L-AP4
Clinical data | |
---|---|
Other names | L-2-Amino-4-phosphonobutyric acid |
Identifiers | |
| |
JSmol) | |
| |
| |
(what is this?) (verify) |
L-AP4 (L-2-amino-4-phosphonobutyric acid) is a drug used in scientific research, which acts as a group-selective agonist for the group III metabotropic glutamate receptors (mGluR4/6/7/8). It was the first ligand found to act as an agonist selective for this group of mGlu receptors,[1] but does not show selectivity between the different mGluR Group III subtypes. It is widely used in the study of this receptor family and their various functions.[2][3][4][5]